Artivion Q2 FY26 GAAP net loss widens to $13.5 million; revenue rises 11% to $125.8 million

Reuters2026/08/06 20:27

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Artivion Q2 2026 revenue rose 11% to USD 125.8 million; GAAP net results swung to a loss of USD 13.5 million.
Adjusted EBITDA increased 7% to USD 26.4 million; non-GAAP net income fell to USD 6.3 million.
U.S. FDA granted PMA approval for the AMDS Hybrid Prosthesis; acquisition of Endospan closed, adding the NEXUS Aortic Arch Stent Graft System.
Full-year 2026 outlook reiterated: revenue USD 480 million to USD 496 million; adjusted EBITDA USD 92 million to USD 99 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artivion Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL21068) on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Artivion Q2 FY26 GAAP net loss widens to $13.5 million; revenue rises 11% to $125.8 million

You may also like

Crypto prices